Clinical Trials Browser

Phase 1 × Suspended × Photons × Clear all

NCT06888323 2026-03-18

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Phase 1 Suspended

Myelodysplastic Syndromes